“Maintenance of Response With Guselkumab for up to 3 Years’ Treatment in the Phase 3 VOYAGE 1 Trial of Patients With Plaque Psoriasis”. 2018. SKIN The Journal of Cutaneous Medicine 2 (December): S90. https://doi.org/10.25251/skin.2.supp.91.